ETAO International Co., Ltd. (ETAOF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
ETAO International Co., Ltd. (ETAOF) with AI Score 44/100 (Weak). ETAO International Co. , Ltd. operates as a digital healthcare company, focusing on integrating online and offline medical services. Sector: Healthcare.
Last analyzed: Mar 16, 2026ETAO International Co., Ltd. (ETAOF) Healthcare & Pipeline Overview
ETAO International Co., Ltd. is a digital healthcare company developing an integrated ecosystem encompassing telemedicine, AI-driven diagnostics, online insurance, and offline medical facilities. The company, incorporated in 2020, aims to provide comprehensive medical care services, positioning itself within the evolving healthcare information services sector.
What Is the Investment Thesis for ETAOF?
ETAO International Co., Ltd. presents a unique investment opportunity within the digital healthcare sector. The company's integrated ecosystem approach, combining telemedicine, AI, and offline facilities, positions it to capitalize on the growing demand for accessible and efficient healthcare solutions. Key value drivers include the expansion of its telemedicine platform, the adoption of AI-driven diagnostics, and the growth of its network of physical clinics. With a beta of 1.50, the stock exhibits higher volatility compared to the market. The company's gross margin stands at 32.7%. However, the company's negative profit margin of -1544.4% raises concerns about its current profitability. Successful execution of its growth strategy and effective cost management will be crucial for achieving sustainable profitability. The pending AI analysis could provide insights into the potential for AI to improve efficiency and patient outcomes. Investors should closely monitor the company's financial performance and progress in expanding its ecosystem.
Based on FMP financials and quantitative analysis
ETAOF Key Highlights
- ETAO International Co., Ltd. operates in the digital healthcare sector, integrating online telemedicine, AI, and offline medical facilities.
- The company's gross margin is 32.7%, indicating a potential for profitability with effective cost management.
- ETAO's beta of 1.50 suggests higher volatility compared to the market.
- The company's profit margin is -1544.4%, highlighting the need for improved financial performance.
- ETAO's business model focuses on creating a comprehensive healthcare ecosystem.
Who Are ETAOF's Competitors?
What Are ETAOF's Key Strengths?
- Integrated healthcare ecosystem combining online and offline services.
- Use of AI for diagnostics and data analysis.
- Network of offline hospitals and specialty clinics.
- Online insurance solutions.
What Are ETAOF's Weaknesses?
- Negative profit margin.
- Limited operating history.
- Dependence on technology and data security.
- Competition from established healthcare providers.
What Could Drive ETAOF Stock Higher?
- Expansion of telemedicine platform to reach a wider patient base.
- Implementation of AI-driven diagnostic tools to improve accuracy and efficiency.
- Growth of offline hospital and clinic network to provide a full spectrum of medical services.
- Development of online insurance solutions to streamline the patient experience.
- Strategic partnerships and acquisitions to expand capabilities and market reach.
What Are the Key Risks for ETAOF?
- Regulatory changes in the healthcare industry could impact the company's operations.
- Data security breaches could compromise patient information and damage the company's reputation.
- Competition from established healthcare providers could limit the company's market share.
- Economic downturn affecting healthcare spending could reduce demand for the company's services.
- Negative profit margin raises concerns about the company's financial sustainability.
What Are the Growth Opportunities for ETAOF?
- Expansion of Telemedicine Platform: ETAO can grow by expanding its telemedicine platform to reach a wider patient base. The global telemedicine market is projected to reach $460 billion by 2030, offering a substantial opportunity for ETAO to increase its market share. By investing in user-friendly technology and expanding its network of healthcare providers, ETAO can attract more patients and generate higher revenue. Timeline: Ongoing.
- Adoption of AI-Driven Diagnostics: ETAO can leverage AI to improve diagnostic accuracy and efficiency. The AI in healthcare market is expected to reach $95 billion by 2030. By implementing AI-powered tools for image analysis, disease prediction, and personalized treatment recommendations, ETAO can enhance patient outcomes and reduce healthcare costs. Timeline: Ongoing.
- Growth of Offline Hospital and Clinic Network: ETAO can expand its network of offline hospitals and specialty clinics to provide a full spectrum of medical services. The global hospital market is projected to reach $4.5 trillion by 2028. By strategically locating new facilities in underserved areas and offering specialized medical services, ETAO can attract more patients and increase its revenue. Timeline: Ongoing.
- Development of Online Insurance Solutions: ETAO can develop and offer online insurance solutions to streamline the patient experience and generate additional revenue. The global online insurance market is projected to reach $400 billion by 2027. By partnering with insurance providers and offering customized insurance plans, ETAO can attract more customers and increase its profitability. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: ETAO can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. By partnering with other healthcare providers, technology companies, and insurance providers, ETAO can gain access to new markets, technologies, and customer segments. Acquisitions can also help ETAO to consolidate its position in the market and gain a competitive advantage. Timeline: Ongoing.
What Opportunities Does ETAOF Have?
- Expansion of telemedicine platform.
- Adoption of AI-driven diagnostics.
- Growth of offline hospital and clinic network.
- Strategic partnerships and acquisitions.
What Threats Does ETAOF Face?
- Regulatory changes in the healthcare industry.
- Data security breaches.
- Competition from established healthcare providers.
- Economic downturn affecting healthcare spending.
What Are ETAOF's Competitive Advantages?
- Integrated healthcare ecosystem providing a comprehensive range of services.
- Proprietary AI-driven diagnostic tools.
- Established network of offline hospitals and specialty clinics.
- Online insurance solutions integrated with healthcare services.
What Does ETAOF Do?
ETAO International Co., Ltd., established in 2020 and based in New York, is a digital healthcare company focused on delivering comprehensive medical care services. The company is building a healthcare ecosystem that integrates various components, including online telemedicine platforms, artificial intelligence for diagnostics and data analysis, online insurance solutions, pharmacy services, biotech research, and a network of offline hospitals and specialty clinics. ETAO's model seeks to provide a seamless healthcare experience, leveraging technology to improve access and efficiency. ETAO's core strategy revolves around creating a synergistic relationship between its online and offline services. The telemedicine platform allows patients to consult with healthcare professionals remotely, while AI and big data analytics are used to enhance diagnostic accuracy and personalize treatment plans. The inclusion of online insurance and pharmacy services further streamlines the patient experience. The physical hospitals and specialty clinics provide a crucial element of in-person care, ensuring that patients have access to a full spectrum of medical services. This integrated approach differentiates ETAO from competitors that focus solely on either online or offline healthcare delivery. ETAO's business model is designed to capture value across the healthcare value chain, from initial consultation to treatment and ongoing care. By controlling multiple touchpoints, the company aims to improve patient outcomes, reduce costs, and generate sustainable revenue streams. The company currently employs 3600 individuals.
What Products and Services Does ETAOF Offer?
- Develops online telemedicine platforms for remote consultations.
- Utilizes artificial intelligence for diagnostics and data analysis.
- Offers online insurance solutions to streamline patient experience.
- Provides pharmacy services for convenient medication access.
- Conducts biotech research to advance medical treatments.
- Operates offline hospitals and specialty clinics for in-person care.
- Integrates online and offline services to create a comprehensive healthcare ecosystem.
How Does ETAOF Make Money?
- Generates revenue through telemedicine consultations.
- Provides AI-driven diagnostic services to healthcare providers.
- Offers online insurance plans to patients.
- Operates pharmacies and generates revenue from medication sales.
What Industry Does ETAOF Operate In?
ETAO International Co., Ltd. operates within the rapidly evolving healthcare information services industry. The industry is driven by increasing demand for accessible, affordable, and efficient healthcare solutions. Telemedicine and AI are playing an increasingly important role in transforming healthcare delivery. The competitive landscape includes companies such as BBLNF (Bloom Burton & Co), CANQF (CareRx Corp), COTQF (CloudMD Software & Services Inc), FORU (Foresight Acquisition Corp I), and LPTI (LifePoint Health Inc), each with varying approaches to digital healthcare. ETAO's integrated ecosystem model aims to differentiate it from competitors focused solely on specific aspects of digital healthcare.
Who Are ETAOF's Key Customers?
- Patients seeking remote medical consultations.
- Healthcare providers utilizing AI-driven diagnostic tools.
- Individuals seeking online insurance plans.
- Patients requiring prescription medications.
ETAOF Financials
ETAOF Latest News
No recent news available for ETAOF.
ETAOF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ETAOF.
Price Targets
Wall Street price target analysis for ETAOF.
ETAOF MoonshotScore
What does this score mean?
The MoonshotScore rates ETAOF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Wensheng Liu
CEO
Wensheng Liu is the CEO of ETAO International Co., Ltd. His background includes extensive experience in managing and scaling technology-driven businesses. He has a proven track record of building successful companies and leading teams to achieve ambitious goals. His expertise spans across various industries, including healthcare, technology, and finance. He is responsible for overseeing the company's overall strategy and operations.
Track Record: Under Wensheng Liu's leadership, ETAO International Co., Ltd. has focused on developing a comprehensive healthcare ecosystem. He has overseen the expansion of the company's telemedicine platform and the implementation of AI-driven diagnostic tools. He has also been instrumental in establishing partnerships with other healthcare providers and technology companies. His strategic decisions have positioned the company for future growth and success.
ETAOF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that ETAO International Co., Ltd. may not meet the minimum financial or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ. These companies often have limited trading volume and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Lower trading volume and liquidity.
- Wider bid-ask spreads.
- Higher price volatility.
- Potential for fraud or manipulation.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price activity.
- Consult with a financial advisor.
- Company incorporation in 2020.
- Headquarters in New York City.
- Business description indicating a focus on digital healthcare.
- CEO identified as Wensheng Liu.
What Investors Ask About ETAO International Co., Ltd. (ETAOF) — Healthcare
What does ETAO International Co., Ltd. do?
ETAO International Co., Ltd. is a digital healthcare company focused on creating an integrated ecosystem of online and offline medical services. This includes telemedicine platforms for remote consultations, AI-driven diagnostic tools, online insurance solutions, pharmacy services, biotech research, and a network of offline hospitals and specialty clinics. The company aims to provide a comprehensive and seamless healthcare experience for patients, leveraging technology to improve access, efficiency, and outcomes. ETAO's model seeks to capture value across the healthcare value chain, from initial consultation to treatment and ongoing care.
What do analysts say about ETAOF stock?
Currently, there is no available analyst coverage or consensus on ETAOF stock. Key valuation metrics include a market cap of $0.00B, a P/E ratio of -0.00, and a profit margin of -1544.4%. The company's gross margin is 32.7%, and its beta is 1.50. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and risk factors before making any investment decisions. The pending AI analysis may provide further insights into the company's potential.
What are the main risks for ETAOF?
ETAOF faces several risks, including regulatory changes in the healthcare industry, data security breaches, competition from established healthcare providers, and the potential for an economic downturn affecting healthcare spending. The company's negative profit margin also raises concerns about its financial sustainability. As an OTC stock, ETAOF is subject to additional risks, such as limited financial disclosure, lower trading volume and liquidity, wider bid-ask spreads, and higher price volatility. Investors should carefully consider these risks before investing in ETAOF.
What are the key factors to evaluate for ETAOF?
ETAO International Co., Ltd. (ETAOF) currently holds an AI score of 44/100, indicating low score. Key strength: Integrated healthcare ecosystem combining online and offline services. Primary risk to monitor: Regulatory changes in the healthcare industry could impact the company's operations. This is not financial advice.
How frequently does ETAOF data refresh on this page?
ETAOF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ETAOF's recent stock price performance?
Recent price movement in ETAO International Co., Ltd. (ETAOF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Integrated healthcare ecosystem combining online and offline services. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ETAOF overvalued or undervalued right now?
Determining whether ETAO International Co., Ltd. (ETAOF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ETAOF?
Before investing in ETAO International Co., Ltd. (ETAOF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited, and the company's future performance is uncertain.
- The OTC market carries additional risks compared to major exchanges.
- AI analysis is pending and may provide further insights.